METHOTREXATE SYSTEMIC CLEARANCE INFLUENCES PROBABILITY OF RELAPSE IN CHILDREN WITH STANDARD-RISK ACUTE LYMPHOCYTIC LEUKAEMIA
- 1 February 1984
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 323 (8373), 359-362
- https://doi.org/10.1016/s0140-6736(84)90411-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Comparison of Intermediate-Dose Methotrexate with Cranial Irradiation for the Post-Induction Treatment of Acute Lymphocytic Leukemia in ChildrenNew England Journal of Medicine, 1983
- Disposition of Intermediate-Dose Methotrexate in Children with Acute Lymphocytic LeukemiaDrug Intelligence & Clinical Pharmacy, 1982
- High-performance liquid chromatographic assay of methotrexate, 7-hydroxymethotrexate, 4-deoxy-4-amino-N10-methylpteroic acid and sulfamethoxazole in serum, urine and cerebrospinal fluidJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- COMPARISON OF THREE METHODS OF CENTRAL-NERVOUS-SYSTEM PROPHYLAXIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1980
- Five-year follow-up of "total therapy" of childhood lymphocytic leukemiaPublished by American Medical Association (AMA) ,1971
- Drug dosage and remission duration in childhood lymphocytic leukemiaCancer, 1971
- A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorshipBiometrika, 1970
- Clinical studies of dichloromethotrexate (NSC 29630)Clinical Pharmacology & Therapeutics, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958